生物皮肤替代品市场－全球产业规模、份额、趋势、机会和预测（按类型、应用、最终用户、地区和竞争细分，2020-2030 年）

2024 年全球生物皮肤替代品市场价值为 3.4147 亿美元，预计到 2030 年将达到 5.585 亿美元，预测期内复合年增长率为 8.52%。市场成长的动力来自于对先进伤口护理日益增长的需求，特别是对于糖尿病溃疡、压疮和烧伤等慢性伤口。生物皮肤替代品透过促进癒合、降低感染风险和改善美容效果，为传统伤口护理提供了更有效、生物相容性的替代方案。再生医学、组织工程和干细胞疗法的技术进步进一步推动了市场的发展。随着医疗保健系统强调改善临床结果和降低长期护理成本，生物皮肤替代品越来越受到关注，特别是在复杂或无法癒合的伤口的治疗方面。外科手术的增加、人口老化以及个人化治疗的创新继续推动市场扩张。

关键市场驱动因素

再生医学的进展

主要市场挑战

成本高且可近性有限

主要市场趋势

个性化客製化解决方案

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球生物皮肤替代品市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依类型（人类供体组织衍生产品、无细胞动物衍生产品、生物合成产品）
  • 按应用（慢性伤口、急性伤口）
  • 按最终使用者（医院和诊所、门诊护理中心、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美生物皮肤替代品市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲生物皮肤替代品市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太生物皮肤替代品市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲生物皮肤替代品市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲生物皮肤替代品市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Organogenesis Inc.
• Integra LifeSciences Corporation
• Smith & Nephew, plc
• Tissue Regenix Group
• MIMEDX Group, Inc.
• Stryker Corporation
• Vericel Corporation
• 3M Company
• Bio-Tissue, Inc.
• Stratatech Corporation

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Biological Skin Substitutes Market was valued at USD 341.47 million in 2024 and is projected to reach USD 558.50 million by 2030, growing at a CAGR of 8.52% during the forecast period. Market growth is being driven by increasing demand for advanced wound care, particularly for chronic wounds such as diabetic ulcers, pressure sores, and burn injuries. Biological skin substitutes offer a more effective and biologically compatible alternative to conventional wound care by enhancing healing, minimizing infection risks, and improving cosmetic outcomes. The market is further fueled by technological progress in regenerative medicine, tissue engineering, and stem cell-based therapies. As healthcare systems emphasize improved clinical outcomes and reduced long-term care costs, biological skin substitutes are gaining traction, especially in the management of complex or non-healing wounds. Increasing surgical procedures, an aging population, and innovation in personalized therapies continue to bolster market expansion.

Key Market Drivers

Advancements in Regenerative Medicine

The growing integration of regenerative medicine in wound care is a key driver of the biological skin substitutes market. Chronic wounds such as diabetic foot ulcers and venous leg ulcers often resist healing through traditional methods. Regenerative medicine-leveraging stem cells, growth factors, and engineered tissue-enables the creation of substitutes that promote faster, more effective tissue repair. FDA approvals of various regenerative therapies highlight their clinical potential. These technologies improve healing outcomes and reduce complications, particularly among elderly patients and those with chronic conditions. The focus on biologically active, personalized solutions for difficult-to-heal wounds underscores the increasing relevance of regenerative therapies in the global market.

Key Market Challenges

High Costs and Limited Accessibility

The high production costs associated with biological skin substitutes pose a substantial barrier to market growth. These products require sophisticated manufacturing processes, such as cell harvesting and tissue engineering, which elevate their price. In low-income and resource-constrained healthcare systems, these costs often place advanced wound care out of reach. Additionally, infrastructure challenges in storing and administering these products-particularly in rural and under-resourced settings-limit their accessibility. Even in developed countries, limited insurance reimbursement and high out-of-pocket costs deter adoption. Addressing affordability and expanding access will be crucial for broader market penetration and improved patient outcomes worldwide.

Key Market Trends

Personalized and Custom-Made Solutions

Personalized wound care is emerging as a major trend in the biological skin substitutes market. Increasingly, treatments are being tailored to individual patient profiles, including autologous skin grafts derived from a patient's own cells. This reduces the risk of immune rejection and enhances healing, particularly for complex wounds or burn injuries. The growth of 3D bioprinting is further enabling the creation of skin substitutes that replicate the structure and functionality of natural skin. These personalized, patient-specific solutions offer superior biological compatibility and regeneration potential. As precision medicine gains momentum in wound care, the demand for custom skin substitutes is expected to accelerate significantly.

Key Market Players

• Organogenesis Inc.
• Integra LifeSciences Corporation
• Smith & Nephew, plc
• Tissue Regenix Group
• MIMEDX Group, Inc.
• Stryker Corporation
• Vericel Corporation
• 3M Company
• Bio-Tissue, Inc.
• Stratatech Corporation

Report Scope:

In this report, the Global Biological Skin Substitutes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biological Skin Substitutes Market, By Type:

• Human Donor Tissue-Derived Products
• Acellular Animal Derived Products
• Biosynthetic Products

Biological Skin Substitutes Market, By Application:

• Chronic Wounds
• Acute Wounds

Biological Skin Substitutes Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Biological Skin Substitutes Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biological Skin Substitutes Market.

Available Customizations:

Global Biological Skin Substitutes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

for export?

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Biological Skin Substitutes Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Human Donor Tissue-Derived Products, Acellular Animal Derived Products, Biosynthetic Products)
  • 5.2.2. By Application (Chronic Wounds, Acute Wounds)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Biological Skin Substitutes Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biological Skin Substitutes Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Biological Skin Substitutes Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Biological Skin Substitutes Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Biological Skin Substitutes Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Biological Skin Substitutes Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Biological Skin Substitutes Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Biological Skin Substitutes Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Biological Skin Substitutes Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Biological Skin Substitutes Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Biological Skin Substitutes Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Biological Skin Substitutes Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Biological Skin Substitutes Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Biological Skin Substitutes Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Biological Skin Substitutes Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Biological Skin Substitutes Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Biological Skin Substitutes Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Biological Skin Substitutes Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Biological Skin Substitutes Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Biological Skin Substitutes Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Biological Skin Substitutes Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Biological Skin Substitutes Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Biological Skin Substitutes Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Biological Skin Substitutes Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Organogenesis Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Integra LifeSciences Corporation
• 14.3. Smith & Nephew, plc
• 14.4. Tissue Regenix Group
• 14.5. MIMEDX Group, Inc.
• 14.6. Stryker Corporation
• 14.7. Vericel Corporation
• 14.8. 3M Company
• 14.9. Bio-Tissue, Inc.
• 14.10. Stratatech Corporation

15. Strategic Recommendations

16. About Us & Disclaimer